{'fraction_non_alphanumeric': 0.04271844660194175, 'fraction_numerical': 0.021359223300970873, 'mean_word_length': 6.068493150684931, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
GMCSF‐Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer

Williams P, Galipeau J (Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada; and Winship Cancer Institute of Emory University, Atlanta, GA, USA). GMCSF‐Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer (Key Symposium). J Intern Med 2011; 269: 74–84.